Skip to main content
Premium Trial:

Request an Annual Quote

Canada PGx Study Seeks Markers for Drug Reactions in Children

NEW YORK (GenomeWeb News) — Canada will start a new pharmacogenomics program to seek predictive genomic markers that could indicate adverse drug reactions in children by harnessing information from an ADR research network that stretches across the country.

The aim of the C$3.9 million ($3.2 million) project is to find out why some drugs cause ADRs in some children and not others, and then to create diagnostic tests to predict and prevent specific reactions, Genome BC said today.

The Canadian Pharmacogenomics Network for Drug Safety (CPNDS) is collecting data from nine of the country’s largest children’s hospitals and will perform large-scale genomic and proteomic studies to identify genes linked to certain ADRs. The results of these studies will be used to develop personalized dosing recommendations.

The research initially will focus on three specific ADRs, including deafness that is induced by the cancer drug Cisplatin, cardiotoxicity caused by the drug anthracycline, which is used to treat leukemia, and infant mortality that is associated with codeine use by the mother.

The project is funded by Genome BC, Pfizer Canada, the University of British Columbia, the Canadian Institute of Health Research, and the Canadian Foundation for Innovation. Institutions involved in the project include the UBC Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, BC Children’s Hospital and BC Women’s Hospital and Health Centre, the Centre for Healthcare Innovation and Improvement, and the University of British Columbia.

According to Health Canada, over 50 percent of newly approved therapeutics have serious ADRs that are discovered after they reach the market, and 75 percent of medications have not been tested in children.

In Canada, ADRs lead to between 10,000 and 22,000 deaths and over C$13 billion in spending per year, Genome BC said.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.